synthetic peptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-07-17. Where a claim depends on a specific study, the study is described rather than over-claimed.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
The peptide was identified during work in the 1970s on thymosin fraction 5, a partially purified extract of calf thymus. Investigators separated that mixture and characterized individual components, one of which they named thymosin alpha-1. The same compound later received the international nonproprietary name thymalfasin. Commercial material is produced by solid-phase peptide synthesis rather than by extraction, so synthetic and natural forms share an identical sequence. Naming conventions vary across the literature, and readers should distinguish the alpha-1 peptide from other thymosins that have unrelated sequences and functions.
Thymosin beta-4 is a separate 43-residue peptide that binds actin and participates in cell migration; it shares no sequence similarity with thymosin alpha-1 despite the common family name. Other preparative materials, such as thymosin fraction 5 and thymopoietin, contain distinct mixtures or peptides. The shared thymosin label reflects the tissue of origin used in early purification, not a common structural core. Treating these molecules as interchangeable is a frequent source of confusion in laboratory reports and in popular summaries alike.
Thymosin alpha-1 is a synthetic peptide of 28 amino acid residues that corresponds to a naturally occurring fragment first isolated from thymus tissue. Its chain is acetylated at the amino terminus, a modification that shields the peptide from rapid cleavage by aminopeptidases. The molecule carries a net negative charge at physiological pH and dissolves freely in water. Researchers classify it as an immune-modulating agent rather than a classical hormone, because it acts on several cell types of both the innate and the adaptive immune system.
| Property | Value | Notes |
|---|---|---|
| Molecular mass | Approximately 3,108 Da | Consistent with a 28-residue acetylated peptide |
| Residue count | 28 | Corresponds to the amino terminal region of prothymosin alpha |
| Appearance of dry powder | White to off-white solid | Slight variation between lots is normal |
| Solubility class | Freely soluble in water | Low solubility in most organic solvents |
| Common synonyms | Thymosin alpha 1, T alpha 1 | The numeral reflects an early fraction numbering scheme |
市售的胸腺素α1通常以冻干粉形式提供，溶解后用于注射。其氨基酸组成包括多个酸性残基，因此在中性pH下带负电荷。该肽可溶于水和生理盐水，但在有机溶剂中溶解度有限。储存条件通常为冻干状态下负20摄氏度，溶解后需冷藏并避免反复冻融。常见的同义词包括胸腺肽α1、thymalfasin和Tα1。
胸腺素α1（thymosin alpha 1，Tα1）是一种由28个氨基酸组成的酸性肽，N端被乙酰化，分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离，属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守，提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置，并非表示亚型编号。它既存在于胸腺，也存在于脾脏和淋巴结等免疫组织。
20世纪70年代，研究者从胸腺提取物中纯化出多种小肽，Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤，产量低且成分复杂。随着固相肽合成技术成熟，实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上，并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。
Most published studies on thymosin alpha-1 report changes in immune measurements rather than clinical outcomes, and findings differ across designs and populations. Whether the peptide signals through one defined receptor or through several less specific interactions remains an open question. Its reported circulation half-life of a few hours complicates comparison of dosing schedules across trials. Mechanistic claims are frequently drawn from isolated cell cultures, and how far those results extend to whole organisms is unresolved.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids whose sequence matches the amino-terminal region of prothymosin alpha. The chain is acetylated at its first residue and contains one disulfide bridge between two cysteine residues, which folds the molecule into a compact loop. Its molecular formula, C129H215N33O55, corresponds to a monoisotopic mass of roughly 3,106 daltons. Material used in laboratories is made by solid-phase synthesis rather than isolated from animal tissue.
Laboratory work indicates that the peptide acts on cells of both the innate and adaptive immune systems. Reported effects include signalling through Toll-like receptors on dendritic cells, enhanced T-cell maturation, and increased natural killer cell activity. These actions are described largely from cell-culture and animal experiments, and the precise receptor-level events remain incompletely defined. Studies in humans have generally measured immune markers rather than a single defined molecular target. The resulting picture remains partly descriptive.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Results across trials have been mixed, and several studies were small or conducted under differing protocols. Regulatory status varies by country, and the compound is not approved in every jurisdiction where it is studied. Evidence for any single indication should be read with attention to sample size and endpoint choice.
Thymosin alpha-1 is a 28-residue peptide first isolated from thymus tissue in the 1970s. It corresponds to the N-terminal portion of thymosin beta-4, from which it is cleaved in vivo. The peptide carries an acetyl group at its N-terminus, a modification that affects its charge and stability. Synthetic material produced by solid-phase peptide synthesis is chemically identical to the natural fragment and is the form used in research and clinical studies.
Thymosin alpha-1 is a synthetic peptide of 28 amino acids, corresponding to the N-terminal fragment of prothymosin alpha. Its sequence begins with acetylation at the N-terminus, a modification that affects stability and receptor interaction. The peptide is acidic, with a calculated isoelectric point near 4.2, and carries no disulfide bonds, so its secondary structure is largely flexible in solution. Molecular mass is approximately 3108 daltons. The native form was first isolated from bovine thymus tissue, while pharmaceutical material is produced by solid-phase peptide synthesis.
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
=== The production of amino acids from inorganic molecules === Sidney Fox based his experiments off of the information found in the Miller–Urey experiment. The Miller–Urey experiment was performed by scientist Stanley Miller under the guidance of Harold Urey in the early 1950s. In the Miller–Urey experiment, water was boiled in a flask with the gases hydrogen, ammonia, and methane. The gases flowed through the apparatus past two electrodes that produced an electrical charge that acted as the lightning that would have been in the atmosphere before life on Earth. When the gases condensed after being cooled down, they fell back into the boiling flask. What Stanley Miller found in the flask when he observed the water were acids and amino acids. Amino acids are the necessary "building block" molecules for proteins. Stanley Miller and Harold Urey's experiment suggests that life formed from the presence of inorganic molecules, water, and electrical charge. These conditions are assumed to be similar to those of primordial earth. In 1964, Fox and Kaoru Harada performed an experiment yielding similar results. In this experiment, methane flowed through a concentrated solution of ammonium hydroxide and then into a hot tube containing silica sand at about 1000 °C. Fox indicated that silica gel, volcanic lava, and alumina could be used in place of silica sand. The gas was then absorbed in cold, aqueous ammonia.
== Definition == There is ongoing debate over how cyberwarfare should be defined and no absolute definition is widely agreed upon. While the majority of scholars, militaries, and governments use definitions that refer to state and state-sponsored actors, other definitions may include non-state actors, such as terrorist groups, companies, political or ideological extremist groups, hacktivists, and transnational criminal organizations depending on the context of the work. Examples of definitions proposed by experts in the field are as follows.
=== Co–Coo === Philip Cohen FRS (b. 1945). At the University of Dundee known primarily for work on protein phosphorylation and ubiquitinylation. Stanley Cohen (1922–2020). American biochemist at Vanderbilt University. Nobel Prize in Physiology or Medicine (1986). Edwin Joseph Cohn (1892–1953). American protein chemist at Harvard, known for studies on blood and the physical chemistry of protein. Author, with John Edsall of Proteins, Amino Acids and Peptides, a very influential book. Member Natl. Acad. Sci. USA. Mildred Cohn (1913–2009). American biochemist, at the University of Pennsylvania, pioneer in the use of nuclear magnetic resonance to study enzyme reactions. Waldo Cohn (1910–1999). American biochemist at Oak Ridge National Laboratory, known for developing techniques for separating isotopes. Linda Columbus (active from 2002). American chemist at the University of Virginia known for work on membrane proteins. Sidney Colowick (1916–1985). American biochemist at Vanderbilt University and founding editor of Methods in Enzymology. Member Natl. Acad. Sci. USA. Minor J. Coon (1921–2018). American biochemist at the University of Michigan, Ann Arbor, discoverer of 3-hydroxy-3-methylglutaryl-CoA.
== Pathophysiology == Articular cartilage is composed of 60-80% water and components of collagens. Its functions are to maintain structure with a lifetime of stress and repetition of movement. Biological repair and cellular turnover is therefore limited leading to the restricted response to traumatic injury. Destruction of the cartilage leads to an activation of an inflammatory cascade leading to regeneration or destruction of the cartilage, the basis of posttraumatic osteoarthritis. These fracture patterns are likely a result of shearing, rotatory, or tangential forces applied to the joint producing segments of both bone and cartilage. The fracture generally run parallel to the joint surface and may be displaced or non displaced. Fragments of this fracture undergo two pathways of healing depending on size and degree of displacement: resorption or loose body formation. If there is vascular communication of the fracture fragment, there is a chance the body will continue to supply that fragment and it will be remained attached to the bone. If there is a disruption of vasculature in the fragment, secondary ossification will occur and the fragment will become a loose body in the joint. With both pathways, there is a continued risk of posttraumatic arthritis and changes to load distribution to the joint.
Sources: en.wikipedia.org
In this way protein dynamics can induce a conformational change in the structure of the protein via long-range allostery with other hydrophobic and hydrophilic residues in the protein. One such example of the regulatory role that phosphorylation plays is the p53 tumor suppressor protein. The p53 protein is heavily regulated and contains more than 18 different phosphorylation sites. Activation of p53 can lead to cell cycle arrest, which can be reversed under some circumstances, or apoptotic cell death. This activity occurs only in situations wherein the cell is damaged or physiology is disturbed in normal healthy individuals. Upon the deactivating signal, the protein becomes dephosphorylated again and stops working. This is the mechanism in many forms of signal transduction, for example the way in which incoming light is processed in the light-sensitive cells of the retina. Regulatory roles of phosphorylation include:
On September 11, 2019, Chief Justice of Ontario George Strathy said that the "cuts to Legal Aid Ontario will force many people to self-represent...What we judges can say is that reducing legal representation for the most vulnerable members of society does not save money. It increases trial times, places greater demands on public services, and ultimately delays and increases the cost of legal proceedings for everyone."
Plants produce chemicals at the injury site that signal the presence of damage and may help to reduce further damage. The chemicals involved depend to some extent on the plant species, though several of them are shared among species; and the signals given depend on the cause of the injury. Plants injured by spider mites release volatile chemicals that attract predatory mites, serving to reduce the attack on the plants. As another example, maize plants damaged by the caterpillars of noctuid moths release a mixture of terpenoid substances which attract the parasitoid wasp Cotesia marginiventris, which kills caterpillars. Many plants give off such herbivory-induced signals.
Chronic inflammation associated with aging has been termed inflammaging, although SASP may be only one of the possible causes of this condition. Chronic systemic inflammation is associated with aging-associated diseases. Senolytic agents have been recommended to counteract some of these effects. Chronic inflammation due to SASP can suppress immune system function, which is one reason elderly persons are more vulnerable to COVID-19.
5 July King Charles III is presented with the Honours of Scotland during a ceremony held at Edinburgh's St Giles Cathedral. The Ministry of Defence confirms that UK Special Forces are at the centre of a war crimes investigation involving Afghanistan. David Black, the chief executive of Ofwat, suggests that water bills are likely to rise in 2025 as water companies seek to cover the cost of improving services. 6 July Two children die, while 15 other people are injured after a Land Rover crashes into a primary school in Wimbledon, south-west London. The crash is not treated as terror-related, but the driver is arrested on suspicion of causing death by dangerous driving. The Parliamentary Commissioner for Standards recommends that MP Chris Pincher be suspended for eight weeks, following an investigation into groping allegations. The government loses a High Court bid to prevent the COVID-19 Inquiry from seeing Boris Johnson's diaries and WhatsApp messages in full. Wallasey pub shooting: Connor Chapman is found guilty of shooting dead 26-year-old Elle Edwards and injuring four others with a submachine gun. Co-defendant Thomas Waring is also found guilty of possessing a prohibited firearm and assisting an offender. The following day, Chapman is sentenced to a minimum of 48 years in prison, and Waring is given a nine-year prison term. 7 July Consumer finance expert Martin Lewis speaks to BBC Radio 4 about the growing use of deepfake AI technology, warning that more regulation is needed to prevent online scams.
Sources: en.wikipedia.org
Computational proteomics is both an interdisciplinary field and a specialization of bioinformatics which uses computational techniques to study the proteome; in particular, computational proteomics is based on peptides identification techniques and allows to integrate vast quantities of heterogeneous data referred to proteins (e.g., identification of proteins, quantification, protein-protein interactions, structures...) and genomics (e.g., expression of genes and expression of proteins). The results of both proteomics and computational proteomics are used by biomedical engineering, biotechnology and Agri-Food Studies.
However, the details of how serpin polymers cause cell death remains to be fully understood. Physiological serpin polymers are thought to form via domain swapping events, where a segment of one serpin protein inserts into another. Domain-swaps occur when mutations or environmental factors interfere with the final stages of serpin folding to the native state, causing high-energy intermediates to misfold. Both dimer and trimer domain-swap structures have been solved. In the dimer (of antithrombin), the RCL and part of the A-sheet incorporates into the A-sheet of another serpin molecule. The domain-swapped trimer (of antitrypsin) forms via the exchange of an entirely different region of the structure, the B-sheet (with each molecule's RCL inserted into its own A-sheet). It has also been proposed that serpins may form domain-swaps by inserting the RCL of one protein into the A-sheet of another (A-sheet polymerisation). These domain-swapped dimer and trimer structures are thought to be the building blocks of the disease-causing polymer aggregates, but the exact mechanism is still unclear.
Partition coefficient log P in −0.4 to +5.6 range Molar refractivity from 40 to 130 Molecular weight from 180 to 480 Number of atoms from 20 to 70 (includes H-bond donors [e.g. OHs and NHs] and H-bond acceptors [e.g. Ns and Os]) Veber's Rule further questions a 500 molecular weight cutoff. The polar surface area and the number of rotatable bonds has been found to better discriminate between compounds that are orally active and those that are not for a large data set of compounds. In particular, compounds which meet only the two criteria of:
=== Routes of administration === Alternative routes of administration, such as insufflation, rectal administration, intravenous, intramuscular, inhalational aerosol, transdermal, or sublingual, avoid or partially avoid the first pass effect because they allow drugs to be absorbed directly into the systemic circulation. Drugs with high first pass effect typically have a considerably higher oral dose than sublingual or parenteral dose. There is marked individual variation in the oral dose due to differences in the extent of first-pass metabolism, frequently among several other factors. Oral bioavailability of many vulnerable drugs appears to be increased in patients with compromised liver function. Bioavailability is also increased if another drug competing for first-pass metabolism enzymes is given concurrently (e.g., propranolol and chlorpromazine).
== April 1942-May 1943 == The division was assigned to XXXXVIII Panzer Corps during the opening phases of Fall Blau (Case Blue), the Wehrmacht's 1942 strategic summer offensive in southern Russia. During the combined Soviet winter offensives Operation Uranus and Operation Mars in late November through mid-December, the division fought near Rzhev, where it was rendered combat ineffective. Called upon to deal with one crisis after another, the division came to be known as die Feuerwehr (the Fire Brigade). By 18 November 1942, the division only had seven Panzer II light tanks, one Panzer III and nineteen Panzer IV medium tanks, and three Sd.Kfz. 265 Panzerbefehlswagen command tanks operational. In January–February 1943, Großdeutschland and XXXXVIII Panzer Corps, along with the II SS Panzer Corps took part in the Third Battle of Kharkov. The division had 5 Panzer IIs, 20 Panzer IIIs, 85 Panzer IVs, 9 Tiger I heavy tanks, 2 Panzerbefehlswagens, and 26 Flammpanzer III flamethrower tank variants of the Panzer III available at that time. The division fought alongside the 1. SS Division Leibstandarte SS Adolf Hitler, 2. SS Division Das Reich and 3. SS Division Totenkopf during these battles. The division's losses as total write-offs at that time amounted to one Panzer III, twelve Panzer IVs, and one Tiger I. After the capture of Kharkov, the Großdeutschland was again pulled back and refitted.
Sources: en.wikipedia.org
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.
It is a 28-residue synthetic peptide studied as an immune-modulating agent and approved as a drug in some countries. The sequence matches a naturally occurring fragment isolated from thymus tissue. It is not a hormone in the endocrine sense.
The name traces back to thymosin fraction 5, a crude thymus extract examined in the 1970s. Individual peptides in that mixture were labeled with Greek letters, and alpha-1 was one of them. The international nonproprietary name thymalfasin was assigned later.
No. Thymosin beta-4 contains 43 residues and binds actin, while thymosin alpha-1 contains 28 residues and acts on immune cells. The two sit in a historical naming group but share no sequence similarity, and they are not substitutes for one another.